A general extracorporeal immunoadsorption method to increase tumor-to-tissue ratio
- 1 February 1994
- Vol. 73 (S3) , 1033-1037
- https://doi.org/10.1002/1097-0142(19940201)73:3+<1033::aid-cncr2820731342>3.0.co;2-q
Abstract
The idea of applying extracorporeal immunoadsorption (ECIA) in radioimmunodiagnosis and radioimmunotherapy has been proposed previously. The authors here report on the development of new concept using a general method for ECIA based on biotinylated MoAb adsorbed on an avidin column. Athymic rats heterotransplanted with either human melanomas or human lung carcinoma were injected with iodine-125-labeled biotinylated 96.5 or L6 MoAb, respectively. At 24 or 48 hours after the injection, ECIA was performed by pumping blood through a hollow-fiber plasma filter. The separated plasma then was passed through an absorbent (avidin-agarose) column. The whole ECIA procedure lasted for 3 hours. By this ECIA method, the tumor-to-normal tissue ratios were increased in various tissues (i.e., radiosensitive and blood rich organs) by a factor of four to five.Keywords
This publication has 9 references indexed in Scilit:
- The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic studyCancer Immunology, Immunotherapy, 1991
- Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column.Radiology, 1991
- Extracorporeal immunoadsorption therapy on rats. In vivo depletion of specific antibodiesClinical and Experimental Immunology, 1990
- Radioimmunotherapy of malignancy using antibody targeted radionuclidesBritish Journal of Cancer, 1986
- Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.Proceedings of the National Academy of Sciences, 1986
- Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.Journal of Clinical Oncology, 1985
- A clinical trial of anti-idiotype therapy for B cell malignancyBlood, 1985